Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
Increasing attention has been given to pollution of the water environment by pharmaceutical compounds discharged from wastewater treatment plants. High-pressure driven membranes such as a nanofiltration (NF) membrane and a reverse osmosis (RO) membrane are considered to be effective for control of pharmaceuticals in wastewater treatment. In practical applications of NF/RO membranes to municipal wastewater treatment, feed water for the membranes always contains organic macromolecules at concentrations of up to 10mg-TOC/L, which are mainly composed of soluble microbial products (SMPs) produced during biological wastewater treatment such as an activated sludge process. In this study, influence of these organic macromolecules on removal of six pharmaceuticals by NF/RO membranes (UTC-60 and LF10) was investigated. Two types of biological treatment (conventional activated sludge process followed by media filtration (i.e., tertiary treatment) and treatment with a membrane bioreactor (MBR)) were examined as pretreatments for NF/RO membranes in this study. In the filtration tests with wastewater effluents, removal of the pharmaceuticals was higher than that seen with deionized pure water spiked with the pharmaceuticals. The increase was significant in the case of the NF membrane. Both alteration of membrane surface properties due to membrane fouling and association of the pharmaceuticals with organic macromolecules contributed to the increase in removal of pharmaceuticals by the membranes. Characteristics of the organic macromolecules contained in the wastewater effluents differed depending on the type of treatment, implying that removal of pharmaceuticals by NF/RO membranes is influenced by the type of pretreatment employed.